Primary efficacy and biomarker analyses from the VISION study of tepotinib in patients (pts) with non-small cell lung cancer (NSCLC) with METex14 skipping Meeting Abstract
| Authors: | Le, X.; Felip, E.; Veillon, R.; Sakai, H.; Cortot, A. B.; Garassino, M. C.; Mazieres, J.; Ramirez, S. V.; Senellart, H.; Van Meerbeeck, J.; Reinmuth, N.; Conte, P. F.; Kowalski, D.; Cho, B. C.; Straub, J.; Scheele, J.; Juraeva, D.; Bruns, R.; Heymach, J.; Paik, P. K. |
| Abstract Title: | Primary efficacy and biomarker analyses from the VISION study of tepotinib in patients (pts) with non-small cell lung cancer (NSCLC) with METex14 skipping |
| Meeting Title: | 56th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 38 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2020 May 29-31 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2020-05-20 |
| Start Page: | 483s |
| Language: | English |
| ACCESSION: | WOS:000560368303457 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2020.38.15_suppl.9556 |
| Notes: | Meeting Abstract: 9556 -- Source: Wos |
